Associations Between Three Polymorphisms in the Interleukin-4 Receptor Gene and Risk of Cancer: a Meta-analysis |
Wang, Jia-Yi
(State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University)
Zhou, Yu-Qiao (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Li, Xiao-Xu (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Jin, Xin (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Wang, Li-Li (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Lei, Lei (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Zhou, Yu (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Lu, Jiang (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Zeng, Xin (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Dan, Hong-Xia (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Liao, Ga (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) Chen, Qian-Ming (State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University) |
1 | Mohan S, Mohanasenthil, Paul SF, Shroff S, Venkatesan V (2009). Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prev, 10, 295-8. |
2 | Nakamura E, Megumi Y, Kobayashi T, et al (2002). Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Clin. Cancer Res, 8, 2620-5. |
3 | Obiri NI, Hillman GG, Haas GP, Sud S, Puri RK (1993). Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest, 91, 88-93. DOI |
4 | Obiri NI, Siegel JP, Varricchio F, Puri RK (1994). Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol, 95, 148-55. |
5 | Olson SH, Orlow I, Simon J, et al (2007). Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. Cancer Detect Prev, 31, 345-51. DOI ScienceOn |
6 | Onishi T, Ohishi Y, Imagawa K, Ohmoto Y, Murata K (1999). An assessment of the immunological environment based on intratumoral cytokine production in renal cell carcinoma. BJU Int, 83, 488-92. |
7 | Ruan Z, Zhao Y, Yan L, et al (2011). Single nucleotide polymorphisms in IL-4Ra, IL-13 and STAT6 genes occurs in brain glioma. Front Biosci, 3, 33-45. DOI |
8 | Sarpatwari A, Bussel JB, Ahmed M, et al (2011). Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology, 16, 243-8. DOI ScienceOn |
9 | Schwartzbaum J, Ahlbom A, Malmer B, et al (2005). Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res, 65, 6459-65. DOI ScienceOn |
10 | Chu H, Ma L, Wang M, Shi D, et al (2012). The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study. Mol Biol Rep, 39, 5349-57. DOI ScienceOn |
11 | Chu H, Wang M, Yan F, et al (2012). Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Ann. Oncol, 23, 2114-21. |
12 | de Visser KE, Eichten A, Coussens LM (2006). Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer, 6, 24-37. DOI ScienceOn |
13 | Engle LJ, Simpson CL, Landers JE (2006). Using high-throughput SNP technologies to study cancer. Oncogene, 25, 1594-601. DOI ScienceOn |
14 | Gooch JL, Christy B, and Yee D (2002). STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. Neoplasia, 4, 324-31. DOI ScienceOn |
15 | Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140, 883-99. DOI ScienceOn |
16 | Hamajima N, Matsuo K, Saito T, et al (2001). Gene-environment Interactions and Polymorphism Studies of Cancer Risk in the Hospital-based Epidemiologic Research Program at Aichi Cancer Center II (HERPACC-II). Asian Pac J Cancer Prev, 2, 99-107. |
17 | Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70. DOI ScienceOn |
18 | Ivansson EL, Gustavsson IM, Magnusson JJ, et al (2007). Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer, 121, 2451-7. DOI ScienceOn |
19 | Sim SH, Ahn YO, Yoon J, et al (2012). Influence of chemotherapy on nitric oxide synthase, indole-amine-2,3-dioxygenase and CD124 expression in granulocytes and monocytes of nonsmall cell lung cancer. Cancer Sci, 103, 155-60. DOI ScienceOn |
20 | Wei BB, Xi B, Wang R, et al (2010). TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies. Cancer Genet Cytogenet, 196, 68-75. DOI ScienceOn |
21 | Welsh MM, Karagas MR, Kuriger JK, et al (2011). Genetic determinants of UV-susceptibility in non-melanoma skin cancer. PLoS One, 6, e20019. DOI |
22 | Wilkening S, Tavelin B, Canzian F, et al (2008). Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis, 29, 1202-06. DOI ScienceOn |
23 | Xia HZ, Du WD, Wu Q, et al (2011). E-selectin rs5361 and FCGR2A rs1801274 variants were associated with increased risk of gastric cancer in a Chinese population. Mol Carcinog, 51, 597-607. |
24 | Johnson LG, Schwartz SM, Malkki M, et al (2011). Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster. Cancer Epidemiol. Biomarkers Prev, 20, 199-207. DOI ScienceOn |
25 | Mitsuyasu H, Izuhara K, Mao XQ, et al (1998). Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet, 19, 119-20. DOI ScienceOn |
26 | Schwartzbaum JA, Ahlbom A, Lonn S, et al (2007). An international case-control study of interleukin-4Ralpha, interleukin-13, and cyclooxygenase-2 polymorphisms and glioblastoma risk. Cancer Epidemiol. Biomarkers Prev, 16, 2448-54. DOI ScienceOn |
27 | Seno H, Satoh K, Tsuji S, et al (2007). Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J. Gastroenterol. Hepatol, 22, 729-37. DOI ScienceOn |
28 | Sheu BC, Chang WC, Cheng CY, et al (2008). Cytokine regulation networks in the cancer microenvironment. Front Biosci, 13, 6255-68. |
29 | Ali KS, Ali HY, Jubr ael JM (2012). Concentration levels of IL-10 and TNF alpha cytokines in patients with human papilloma virus (HPV) DNA(+) and DNA(-) cervical lesions. J Immunotoxicol, 9, 168-72. DOI ScienceOn |
30 | Ames BN, Gold LS, Willett WC (1995). The causes and prevention of cancer. Proc Natl Acad Sci USA, 92, 5258-65. DOI ScienceOn |
31 | Balasubramanian SP, Azmy IA, Higham SE, et al (2006). Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer, 6, 188. DOI |
32 | Brenner AV, Butler MA, Wang SS, et al (2007). Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis, 28, 2543-7. DOI ScienceOn |
33 | Brown EE, Lan Q, Zheng T, Zhang Y, et al (2007). Common variants in genes that mediate immunity and risk of multiple myeloma. Int. J. Cancer, 120, 2715-22. DOI ScienceOn |
34 | Castro FA, Haimila K, Sareneva I, et al (2009). Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int. J. Cancer, 125, 1851-8. DOI ScienceOn |
![]() |